Full Text
Full Text PDF
Abstract
Background: People who inject drugs (PWID) should be treated in order to eliminate hepatitis C virus in the world. The aim of this study was to compare direct-acting antivirals treatment of hepatitis C virus for PWID and non-PWID in a real-life setting. Methods: We performed a prospective, non-randomized, observational multicenter cohort study in 37 centers. All patients treated with direct-acting antivirals between April 1, 2017, and February 28, 2019, were included. In total, 2713 patients were included in the study among which 250 were PWID and 2463 were non-PWID. Besides patient characteristics, treatment response, follow-up, and side effects of treatment were also analyzed. Results: Genotype 1a and 3 were more prevalent in PWID-infected patients (20.4% vs 9.9% and 46.8% vs 5.3%). The number of naïve patients was higher in PWID (90.7% vs 60.0%), while the number of patients with cirrhosis was higher in non-PWID (14.1% vs 3.7%). The loss of follow-up was higher in PWID (29.6% vs 13.6%). There was no difference in the sustained virologic response at 12 weeks after treatment (98.3% vs 98.4%), but the end of treatment response was lower in PWID (96.2% vs 99.0%). In addition, the rate of treatment completion was lower in PWID (74% vs 94.4%). Conclusion: Direct-acting antivirals were safe and effective in PWID. Primary measures should be taken to prevent the loss of follow-up and poor adherence in PWID patients in order to achieve World Health Organization’s objective of eliminating viral hepatitis Cite this article as: Sarıgül Yıldırım F, Üser Ü, Sarı ND, et al. In a real-life setting, direct-acting antivirals to people who inject drugs with chronic hepatitis C in Turkey. Turk J Gastroenterol. 2022;33(11):971-978
Most read articles by the same author(s)
- Bilal Toka, Emel Gönüllü, Mukaddes Tozlu, Ahmet Tarik Eminler, Mustafa Ihsan Uslan, Aydın Şeref Köksal, Oğuz Karabay, Evaluation of rheumatologists’ awareness of hepatitis B reactivation before immunosuppressive treatment , Turkish Journal of Gastroenterology: Vol. 30 No. Supplement 1 (2019): Volume 30 Issue S1 (2019)
- Selma Tosun, Seher Ayten Coskuner, Irem Altas, Diagnosis ways of chronic HBV cases , Turkish Journal of Gastroenterology: Vol. 30 No. Supplement 1 (2019): Volume 30 Issue S1 (2019)
- Rahmet ÇAYLAN, Kemalettin AYDIN, İftihar KÖKSAL, Recep ÖKSÜZ, Uğur KOSTAKOĞLU, Ümit ÇOBANOĞLU, Nurucihan ARI, Sevim AYDIN, Evaluation of the outcome of interferon therapy in chronic hepatitis B infection , Turkish Journal of Gastroenterology: Vol. 10 No. 3 (1999): Turkish Journal of Gastroenterology
- Selma Tosun, Seher Ayten Coskuner, Hulya Bayık, Long-term impact on health vocational high school students 20 years after national HBV vaccination , Turkish Journal of Gastroenterology: Vol. 30 No. Supplement 1 (2019): Volume 30 Issue S1 (2019)
- Gokhan Tosun, Selma Tosun, Funda Balaylar, Does HBsAg positivity change in pregnancy? , Turkish Journal of Gastroenterology: Vol. 30 No. Supplement 1 (2019): Volume 30 Issue S1 (2019)
- Fehmi Tabak, Behice Kurtaran, Esra Zerdali, Selma Tosun, Şaban Esen, Nefie Çuvalcı Öztoprak, Kamuran Türker, Nagehan Didem Sarı, Yusuf Önlen, Tansu Yamazhan, Kenan Hızel, Hepcturkey Study Group, Direct acting antivirals are effective and safe in intravenous drug users with chronic HCV Preview of your abstract file infection: First report from Turkey , Turkish Journal of Gastroenterology: Vol. 30 No. Supplement 1 (2019): Volume 30 Issue S1 (2019)
- Selma Tosun, Ilknur Esen Yildiz, Semra Sen, Kenan Ugurlu, Handan Alaylı, Aysenur Bahsi, Seher Ayten Coskuner, The importance of HBV testing during pregnancy and immunization and current HBV situation of babies , Turkish Journal of Gastroenterology: Vol. 30 No. Supplement 1 (2019): Volume 30 Issue S1 (2019)
- Bilgehan Aygen, Neşe Demirtürk, Orhan Yıldız, Mustafa Kemal Çelen, Ilhami Çelik, Şener Barut, Onur Ural, Ayşe Batırel, Reşit Mıstık, Funda Şimşek, Ali Asan, Gülden Ersöz, Nesrin Türker, Hüseyin Bilgin, Çiğdem Ataman Hatipoğlu, Faruk Karakeçili, A A, Real-world efficacy, safety and clinical outcomes of ombitasvir/ paritaprevir/ ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: Turkey experience , Turkish Journal of Gastroenterology: Vol. 30 No. Supplement 1 (2019): Volume 30 Issue S1 (2019)
- Özgür Günal, Şener Barut, İlker Etikan, Fazilet Duygu, Umut Tuncel, Mustafa Sünbül, Relation between serum quantitative HBsAg, ALT and HBV DNA levels in HBeAg negative chronic HBV infection , Turkish Journal of Gastroenterology: Vol. 25 No. 1 (2014): Turkish Journal of Gastroenterology
- Emine Şeyma Denli Yalvaç, Mustafa Aldağ, Cemal Kocaaslan, Ebubekir Şenateş, Ebuzer Aydın, Acute pancreatitis after coronary artery bypass surgery treated by plasmapheresis , Turkish Journal of Gastroenterology: Vol. 29 No. 1 (2018): Turkish Journal of Gastroenterology
Article Info
Published In
Journal
Turkish Journal of Gastroenterology
Volume / Issue
Volume 33 · Issue 11
Pages
971-978
History
Published Online
November 15, 2022
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright
Copyright (c) 2022 Figen Sarıgül Yıldırım, Ülkü Üser, Nagehan Didem Sarı, Behice Kurtaran, Yusuf Önlen, Ebubekir Şenateş, Alper Gündüz, Esra Zerdali, Hasan Karsen, Ayşe Batırel, Rıdvan Karaali, Rahmet Güner, Tansu Yamazhan, Şükran Köse, Nurettin Erben, Nevin İnce, İftihar Köksal, Nefise Çuvalcı Öztoprak, Gülşen Yörük, Süheyla Kömür, Tayibe Bal, Sibel Kaya, İlkay Bozkurt, Özgür Günal, İlknur Esen Yıldız, Dilara İnan, Şener Barut, Mustafa Namıduru, Selma Tosun, Kamuran Türker, Alper Şener, Kenan Hızel, Nurcan Baykam, Fazilet Duygu, Hürrem Bodur, Güray Can, Hanefi Cem Gül, Ayşe Sağmak Tartar, Güven Çelebi, Mahmut Sünnetçioğlu, Oğuz Karabay, Hayat Kumbasar Karaosmanoğlu, Fatma Sırmatel, Fehmi Tabak
Affiliations
Figen Sarıgül Yıldırım
Department of Infectious Diseases, Antalya Training and Research Hospital, Antalya, Turkey
Ülkü Üser
Department of Infectious Diseases and Clinical Microbiology, Antalya Training and Research Hospital, Antalya, Turkey
Nagehan Didem Sarı
Departments of Clinical Microbiology and Infectious Diseases, İstanbul Education and Research Hospital, İstanbul
Behice Kurtaran
Department of Infectious Diseases, Çukurova University Faculty of Medicine, Adana, Turkey
Yusuf Önlen
Turkish Association for the Study of the Liver, Istanbul, Turkey; Viral Hepatitis Society, Ankara, Turkey
Ebubekir Şenateş
Department of Gastroenterology, İstanbul Medeniyet University Göztepe Training and Research Hospital, İstanbul, Turkey
Alper Gündüz
Department of Infectious Diseases, Şişli Hamidiye Etfal Training and Research Hospital, İstanbul, Turkey
Esra Zerdali
Haseki Training and Research Hospital Department of Infectious Diseases, İstanbul, Turkey
Hasan Karsen
Harran University Faculty of Medicine Infectious Diseases Department, Şanlıurfa, Turkey
Ayşe Batırel
Department of Infectious Diseases and Clinical Microbiology, Dr. Lütfi Kırdar Kartal Education and Research Hospital, İstanbul, Turkey
Rıdvan Karaali
Department of Infectious Diseases and Clinical Microbiology, Tekirdağ Namık Kemal University Faculty of Medicine, Tekirdağ, Turkey
Rahmet Güner
Department of Infectious diseases, Yıldırım Beyazıt University Faculty of Medicine, Ankara, Turkey
Tansu Yamazhan
Turkish Association for the Study of the Liver, İstanbul, Turkey; Viral Hepatitis Society, Ankara, Turkey
Şükran Köse
Clinics of Infectious Diseases and Clinical Microbiology, Ministry of Health İzmir Tepecik Education and Research Hospital, İzmir
Nurettin Erben
Department of Infectious Diseases and Clinical Microbiology, Eskişehir Osman Gazi University, Eskişehir, Turkey
Nevin İnce
Düzce Üniversity, Düzce, Turkey
İftihar Köksal
KTÜ Tıp Fakültesi İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalı, Trabzon
Nefise Çuvalcı Öztoprak
Antalya Training and Research Hospital, Infectious Diseases, Antalya, Turkey
Gülşen Yörük
Department of Infectious Diseases, İstanbul Training and Research Hospital, İstanbul, Turkey
Süheyla Kömür
Department of Infectious Diseases, Çukurova University Faculty of Medicine, Adana, Turkey
Tayibe Bal
Mustafa Kemal University Faculty of Medicine, Antakya, Turkey
Sibel Kaya
Istanbul University Faculty of Medicine Infectious Diseases Department, İstanbul, Turkey
İlkay Bozkurt
Department of Infectious Diseases and Clinical Microbiology, Ondokuz Mayıs University Faculty of Medicine, Samsun, Turkey
Özgür Günal
Department of Infectious Diseases and Clinical Microbiology, Gaziosmanpaşa Universtiy Faculty of Medicine, Tokat, Turkey
İlknur Esen Yıldız
Department of Infectious Diseases and Clinical Microbiology, Rize University School of Medicine, Rize, Turkey
Dilara İnan
Turkish Association for the Study of the Liver, İstanbul, Turkey; Viral Hepatitis Society, Ankara, Turkey
Şener Barut
Departments of Clinical Bacteriology and Infectious Disease, Gaziosmanpafla University, School of Medicine, Tokat
Mustafa Namıduru
Department of Infectious Diseases and Clinical Microbiology, Gaziantep University Faculty of Medicine, Gaziantep, Turkey
Selma Tosun
Turkish Association for the Study of the Liver, Istanbul, Turkey; Viral Hepatitis Society, Ankara, Turkey
Kamuran Türker
Bağcılar Training and Research Hospital Department of Infectious Diseases, İstanbul, Turkey
Alper Şener
Department of Infectious Diseases and Clinical Microbiology, Çanakkale Onsekiz Mart University Faculty of Medicine, Çanakkale, Turkey
Kenan Hızel
Gazi University Faculty of Medicine Infectious Diseases Department, Ankara, Turkey
Nurcan Baykam
Ankara Numune Hospital, Enfeksiyon Hospital, Infection Diseases and Clinical Microbiology Department, Ankara
Fazilet Duygu
Department of Infectious Diseases and Clinical Microbiology, Gaziosmanpaşa Universtiy Faculty of Medicine, Tokat, Turkey
Hürrem Bodur
Turkish Association for the Study of the Liver, İstanbul, Turkey; Viral Hepatitis Society, Ankara, Turkey
Güray Can
Department of Gastroenterology, Abant İzzet Baysal University School of Medicine, Bolu, Turkey
Hanefi Cem Gül
Department of Infectious Diseases, Gülhane Training and Research Hospital, Ankara, Turkey
Ayşe Sağmak Tartar
Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Fırat University, Elazığ, Turkey
Güven Çelebi
Department of Infectious Diseases and Clinical Microbiology, Bülent Ecevit University Faculty of Medicine, Zonguldak, Turkey
Mahmut Sünnetçioğlu
Department of Infectious Diseases and Clinical Microbiology, Yüzüncü Yıl University Faculty of Medicine, Van, Turkey
Oğuz Karabay
Infectious Diseases Department İzzet Baysal Medical Faculty
Hayat Kumbasar Karaosmanoğlu
Bakırköy Sadi Konuk Training and Research Hospital, Infectious Diseases Department, İstanbul, Turkey
Fatma Sırmatel
Turkish Association for the Study of the Liver, İstanbul, Turkey; Viral Hepatitis Society, Ankara, Turkey
Fehmi Tabak
İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi İç Hastalıkları, Kardiyoloji, Patoloji Anabilim Dalları, İstanbul
Cite this Article
Sarıgül Yıldırım, F., Üser, Ülkü, Sarı, N. D., Kurtaran, B., Önlen, Y., Şenateş, E., … Tabak, F. (2022). In a Real-Life Setting, Direct-Acting Antivirals to People Who Inject Drugs with Chronic Hepatitis C in Turkey. Turkish Journal of Gastroenterology, 33(11), 971–978. https://doi.org/10.5152/tjg.2022.21834
Outlines